Embla Medical hf. (OSSFF)
OTCMKTS · Delayed Price · Currency is USD
4.150
+0.070 (1.72%)
At close: Mar 21, 2025
Embla Medical Revenue
Embla Medical had revenue of $232.42M in the quarter ending June 30, 2025, with 7.24% growth. This brings the company's revenue in the last twelve months to $873.51M, up 6.57% year-over-year. In the year 2024, Embla Medical had annual revenue of $854.89M with 8.81% growth.
Revenue (ttm)
873.51M
Revenue Growth
+6.57%
P/S Ratio
2.43
Revenue / Employee
218.38K
Employees
4,061
Market Cap
2.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 854.89M | 69.21M | 8.81% |
| Dec 31, 2023 | 785.68M | 67.03M | 9.33% |
| Dec 31, 2022 | 718.65M | -19.00K | -0.00% |
| Dec 31, 2021 | 718.67M | 89.17M | 14.16% |
| Dec 31, 2020 | 629.50M | -56.76M | -8.27% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 84.04M |
| Glass House Brands | 215.62M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.70M |
Embla Medical News
- 13 days ago - Embla Medical hf: Interim Report Q2 2025 - PRNewsWire
- 1 year ago - Ukrainian medical professionals receive comprehensive training in the field of lower limb prosthetics: Össur - PRNewsWire